PortfoliosLab logo
ALAR vs. SLNO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALAR and SLNO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ALAR vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alarum Technologies Ltd. (ALAR) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

ALAR:

-0.69

SLNO:

1.01

Sortino Ratio

ALAR:

-0.75

SLNO:

1.85

Omega Ratio

ALAR:

0.91

SLNO:

1.22

Calmar Ratio

ALAR:

-0.69

SLNO:

0.63

Martin Ratio

ALAR:

-0.99

SLNO:

4.59

Ulcer Index

ALAR:

69.02%

SLNO:

12.81%

Daily Std Dev

ALAR:

109.86%

SLNO:

66.06%

Max Drawdown

ALAR:

-99.94%

SLNO:

-99.86%

Current Drawdown

ALAR:

-99.69%

SLNO:

-88.83%

Fundamentals

Market Cap

ALAR:

$57.08M

SLNO:

$3.78B

EPS

ALAR:

$0.80

SLNO:

-$4.74

PS Ratio

ALAR:

1.79

SLNO:

0.00

PB Ratio

ALAR:

2.17

SLNO:

16.28

Total Revenue (TTM)

ALAR:

$23.45M

SLNO:

$0.00

Gross Profit (TTM)

ALAR:

$17.34M

SLNO:

-$494.00K

EBITDA (TTM)

ALAR:

$4.91M

SLNO:

-$156.82M

Returns By Period

In the year-to-date period, ALAR achieves a -24.98% return, which is significantly lower than SLNO's 63.07% return.


ALAR

YTD

-24.98%

1M

9.49%

6M

-36.42%

1Y

-74.67%

3Y*

13.11%

5Y*

-9.20%

10Y*

N/A

SLNO

YTD

63.07%

1M

6.34%

6M

33.69%

1Y

65.57%

3Y*

198.35%

5Y*

4.09%

10Y*

-13.91%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alarum Technologies Ltd.

Soleno Therapeutics, Inc.

Risk-Adjusted Performance

ALAR vs. SLNO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALAR
The Risk-Adjusted Performance Rank of ALAR is 1717
Overall Rank
The Sharpe Ratio Rank of ALAR is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of ALAR is 1717
Sortino Ratio Rank
The Omega Ratio Rank of ALAR is 1919
Omega Ratio Rank
The Calmar Ratio Rank of ALAR is 99
Calmar Ratio Rank
The Martin Ratio Rank of ALAR is 2626
Martin Ratio Rank

SLNO
The Risk-Adjusted Performance Rank of SLNO is 8181
Overall Rank
The Sharpe Ratio Rank of SLNO is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of SLNO is 8383
Sortino Ratio Rank
The Omega Ratio Rank of SLNO is 8080
Omega Ratio Rank
The Calmar Ratio Rank of SLNO is 7676
Calmar Ratio Rank
The Martin Ratio Rank of SLNO is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALAR vs. SLNO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alarum Technologies Ltd. (ALAR) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ALAR Sharpe Ratio is -0.69, which is lower than the SLNO Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of ALAR and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

ALAR vs. SLNO - Dividend Comparison

Neither ALAR nor SLNO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALAR vs. SLNO - Drawdown Comparison

The maximum ALAR drawdown since its inception was -99.94%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for ALAR and SLNO. For additional features, visit the drawdowns tool.


Loading data...

Volatility

ALAR vs. SLNO - Volatility Comparison

Alarum Technologies Ltd. (ALAR) has a higher volatility of 16.63% compared to Soleno Therapeutics, Inc. (SLNO) at 7.98%. This indicates that ALAR's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

ALAR vs. SLNO - Financials Comparison

This section allows you to compare key financial metrics between Alarum Technologies Ltd. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00M4.00M6.00M8.00M20212022202320242025
7.37M
0
(ALAR) Total Revenue
(SLNO) Total Revenue
Values in USD except per share items